Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding

Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: امیررضا ناصری , سپیده سیدی صاحباری , سیدمحمدسالار حسینی

کلمات کلیدی: Angiotensin converting enzyme 2, breast feeding, drug therapy, pregnancy, severe acute respiratory syndrome coronavirus 2

نشریه: 0 , 1 , 7 , 2021

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سیدمحمدسالار حسینی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات پزشکی مبتنی بر شواهد EBM
کد مقاله 78710
عنوان فارسی مقاله Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding
عنوان لاتین مقاله Pharmacotherapy of COVID-19: Considerations for Pregnancy and Breastfeeding
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Journal of Obstetrics, Gynecology and Cancer Research
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح سه – Scopus
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a chief concern of the international community. As of May 2021, more than 150 million cases and 3.2 million deaths have been recorded. Considering the early struggle in treating COVID-19 patients, the researchers and clinicians have decided to try the previously available drugs according to their mechanisms of action. This article aims to review the potential drugs for COVID-19 patients during pregnancy and breastfeeding and their safety. PubMed and Scopus databases and Google Scholar engine were searched with the proper combination of the free keywords and MeSH Terms of COVID-19, SARS-CoV-2, Pregnancy, Breastfeeding, Treatment, Pharmacotherapy, Drug Therapy, and Drug Safety. All relevant clinical studies published until the end of 2020 were included in this review. Many antivirals, antibiotics, antiparasitics, and antipyretics have been proposed, but most of them are not registered for COVID-19 or have demonstrated little effect on the disease. Since there is still a long way to find an effective drug for the treatment of COVID-19, prevention is currently the most effective way. Also, prescribing drugs to these two groups of patients should be done according to the safety recommendations.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
امیررضا ناصریاول
سپیده سیدی صاحباریدوم
سیدمحمدسالار حسینیسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
jogcr-v7n1p1-en.pdf1401/02/25318440دانلود